• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非动脉瘤性蛛网膜下腔出血的临床结局及预后不良的预测因素:一项10年队列分析

Clinical Outcomes and Predictors of Poor Prognosis in Non-aneurysmal Subarachnoid Hemorrhage: A 10-Year Cohort Analysis.

作者信息

Nogueira João, Meireles Bernardo, Pereira Renato, Ribeiro Pedro, Marques Renata, Afonso Filipe Miguel, Coimbra Frederica

机构信息

Neurosurgery, Hospital de Braga, Braga, PRT.

Neurosurgery, Escola de Medicina da Universidade do Minho, Braga, PRT.

出版信息

Cureus. 2024 Dec 12;16(12):e75596. doi: 10.7759/cureus.75596. eCollection 2024 Dec.

DOI:10.7759/cureus.75596
PMID:39803087
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11724691/
Abstract

Introduction A large majority of spontaneous subarachnoid hemorrhages (SAH) are attributed to aneurysm rupture, though the cause remains unknown in a notable percentage of cases. Non-aneurysmal SAH (naSAH) is generally thought to follow a more benign clinical course than aneurysmal SAH (aSAH); however, similar complications may occur, and poor outcomes are still possible. Given the limited research on naSAH, this study aims to characterize these patients and correlate clinical and radiographic findings with outcomes. Methods A cohort of 149 patients with naSAH was selected from 2014 to 2023. Outcomes were assessed using the modified Rankin Scale (mRS), categorizing results as favorable (mRS 0-2) or unfavorable (mRS 3-6). Descriptive analysis was conducted, dividing the sample into two groups based on blood distribution on computed tomography scan: pretruncal (pnSAH) and non-pretruncal SAH (npnSAH). Associations between variables were tested, and a multivariable logistic regression was performed to identify significant predictors. Results The mean age was 57.54 years, with 79 males (53.0%) and 70 females (47.0%). A favorable outcome was observed in 133 patients (89.3%). Age, chronic hypertension, anticoagulant, and antiplatelet therapy were significant predictors of poor outcome (p < 0.05). A favorable World Federation of Neurosurgical Societies (WFNS) grade (I-III) was recorded in 88.6% of patients and was significantly associated with outcome (p < 0.05). Among the patients with unfavorable outcomes, 87.5% exhibited a npnSAH pattern. Rebleeding was rare, with only one case (0.7%). Acute hydrocephalus was the primary complication observed in naSAH cases (19.5%). Conclusions Patients with a npnSAH pattern were significantly more likely to experience unfavorable outcomes compared to those with a pnSAH pattern. In multivariate regression analysis, WFNS classification, bleeding pattern (pnSAH vs. npnSAH), and acute hydrocephalus were identified as independent predictors of poor outcomes.

摘要

引言 大多数自发性蛛网膜下腔出血(SAH)归因于动脉瘤破裂,尽管在相当比例的病例中病因仍不明。非动脉瘤性SAH(naSAH)通常被认为比动脉瘤性SAH(aSAH)的临床病程更良性;然而,类似的并发症可能发生,不良结局仍有可能。鉴于对naSAH的研究有限,本研究旨在对这些患者进行特征描述,并将临床和影像学结果与结局相关联。方法 从2014年至2023年选取了149例naSAH患者。使用改良Rankin量表(mRS)评估结局,将结果分为良好(mRS 0 - 2)或不良(mRS 3 - 6)。进行描述性分析,根据计算机断层扫描上的血液分布将样本分为两组:脑干前(pnSAH)和非脑干前SAH(npnSAH)。测试变量之间的关联,并进行多变量逻辑回归以确定显著的预测因素。结果 平均年龄为57.54岁,男性79例(53.0%),女性70例(47.0%)。133例患者(89.3%)观察到良好结局。年龄、慢性高血压、抗凝和抗血小板治疗是不良结局的显著预测因素(p < 0.05)。88.6%的患者记录到良好的世界神经外科联合会(WFNS)分级(I - III),且与结局显著相关(p < 0.05)。在结局不良的患者中,87.5%表现为npnSAH模式。再出血罕见,仅1例(0.7%)。急性脑积水是naSAH病例中观察到的主要并发症(19.5%)。结论 与pnSAH模式的患者相比,npnSAH模式的患者发生不良结局的可能性显著更高。在多变量回归分析中,WFNS分级、出血模式(pnSAH与npnSAH)和急性脑积水被确定为不良结局的独立预测因素。

相似文献

1
Clinical Outcomes and Predictors of Poor Prognosis in Non-aneurysmal Subarachnoid Hemorrhage: A 10-Year Cohort Analysis.非动脉瘤性蛛网膜下腔出血的临床结局及预后不良的预测因素:一项10年队列分析
Cureus. 2024 Dec 12;16(12):e75596. doi: 10.7759/cureus.75596. eCollection 2024 Dec.
2
Increasing numbers of nonaneurysmal subarachnoid hemorrhage in the last 15 years: antithrombotic medication as reason and prognostic factor?过去15年非动脉瘤性蛛网膜下腔出血病例数增加:抗血栓药物是原因及预后因素吗?
J Neurosurg. 2016 Jun;124(6):1731-7. doi: 10.3171/2015.5.JNS15161. Epub 2015 Nov 13.
3
Complications after angiogram-negative subarachnoid haemorrhage: comparative study of pretruncal and nonpretruncal hemorrhage patients.血管造影阴性的蛛网膜下腔出血后的并发症:延髓前出血与非延髓前出血患者的比较研究
Srp Arh Celok Lek. 2012 Jan-Feb;140(1-2):8-13.
4
Neutrophil-to-lymphocyte ratio as an independent predictor for unfavorable functional outcome in aneurysmal subarachnoid hemorrhage.中性粒细胞与淋巴细胞比值可作为动脉瘤性蛛网膜下腔出血不良功能结局的独立预测因子。
J Neurosurg. 2019 Feb 1;132(2):400-407. doi: 10.3171/2018.9.JNS181975. Print 2020 Feb 1.
5
Exploration of Risk Factors for Poor Prognosis of Non-Traumatic Non-Aneurysmal Subarachnoid Hemorrhage.探讨非创伤性非脑动脉瘤性蛛网膜下腔出血预后不良的危险因素。
Biomolecules. 2022 Jul 6;12(7):948. doi: 10.3390/biom12070948.
6
Predictors of excellent functional outcome in aneurysmal subarachnoid hemorrhage.动脉瘤性蛛网膜下腔出血功能预后良好的预测因素。
J Neurosurg. 2015 Feb;122(2):414-8. doi: 10.3171/2014.10.JNS14290. Epub 2014 Dec 12.
7
Preoperative and postoperative predictors of long-term outcome after endovascular treatment of poor-grade aneurysmal subarachnoid hemorrhage.血管内治疗差分级动脉瘤性蛛网膜下腔出血的长期预后的术前和术后预测因素。
J Neurosurg. 2017 Jun;126(6):1764-1771. doi: 10.3171/2016.4.JNS152587. Epub 2016 Jul 1.
8
Validation of the accuracy of the modified World Federation of Neurosurgical Societies subarachnoid hemorrhage grading scale for predicting the outcomes of patients with aneurysmal subarachnoid hemorrhage.验证改良的世界神经外科学会蛛网膜下腔出血分级量表预测动脉瘤性蛛网膜下腔出血患者结局的准确性。
PLoS One. 2023 Aug 22;18(8):e0289267. doi: 10.1371/journal.pone.0289267. eCollection 2023.
9
Cerebral vasospasm and delayed cerebral infarctions in 225 patients with non-aneurysmal subarachnoid hemorrhage: the underestimated risk of Fisher 3 blood distribution.225例非动脉瘤性蛛网膜下腔出血患者的脑血管痉挛和迟发性脑梗死:Fisher 3级血液分布风险被低估
J Neurointerv Surg. 2016 Dec;8(12):1247-1252. doi: 10.1136/neurintsurg-2015-012153. Epub 2016 Feb 4.
10
Effect of stress-induced hyperglycemia after non-traumatic non-aneurysmal subarachnoid hemorrhage on clinical complications and functional outcomes.非创伤性非动脉瘤性蛛网膜下腔出血后应激性高血糖对临床并发症及功能转归的影响
CNS Neurosci Ther. 2022 Jun;28(6):942-952. doi: 10.1111/cns.13826. Epub 2022 Mar 15.

本文引用的文献

1
Postinterventional Petechial Hemorrhage Associated With Poor Functional Outcome After Successful Recanalization Following Endovascular Therapy.血管内治疗成功再通后,介入后瘀点性出血与功能预后不良相关。
Neurosurgery. 2025 Feb 1;96(2):438-446. doi: 10.1227/neu.0000000000003098. Epub 2024 Jul 10.
2
The clinical course and outcomes of non-aneurysmal subarachnoid hemorrhages in a single-center retrospective study.一项单中心回顾性研究中非动脉瘤性蛛网膜下腔出血的临床过程和转归。
Acta Neurochir (Wien). 2023 Oct;165(10):2843-2853. doi: 10.1007/s00701-023-05767-4. Epub 2023 Sep 2.
3
Validation of the accuracy of the modified World Federation of Neurosurgical Societies subarachnoid hemorrhage grading scale for predicting the outcomes of patients with aneurysmal subarachnoid hemorrhage.验证改良的世界神经外科学会蛛网膜下腔出血分级量表预测动脉瘤性蛛网膜下腔出血患者结局的准确性。
PLoS One. 2023 Aug 22;18(8):e0289267. doi: 10.1371/journal.pone.0289267. eCollection 2023.
4
Effect of atrial fibrillation on outcomes in patients with anterior circulation occlusion stroke receiving endovascular therapy.心房颤动对接受血管内治疗的前循环闭塞性卒中患者预后的影响。
Front Aging Neurosci. 2023 Jun 15;15:1160265. doi: 10.3389/fnagi.2023.1160265. eCollection 2023.
5
2023 Guideline for the Management of Patients With Aneurysmal Subarachnoid Hemorrhage: A Guideline From the American Heart Association/American Stroke Association.2023 颅内动脉瘤性蛛网膜下腔出血患者管理指南:美国心脏协会/美国卒中协会指南
Stroke. 2023 Jul;54(7):e314-e370. doi: 10.1161/STR.0000000000000436. Epub 2023 May 22.
6
Hydrocephalus, cerebral vasospasm, and delayed cerebral ischemia following non-aneurysmatic spontaneous subarachnoid hemorrhages: an underestimated problem.非动脉瘤性自发性蛛网膜下腔出血后继发脑积水、脑血管痉挛和迟发性脑缺血:一个被低估的问题。
Neurosurg Rev. 2022 Dec 22;46(1):23. doi: 10.1007/s10143-022-01919-9.
7
Diffuse Angiogram-Negative Subarachnoid Hemorrhage is Associated with an Intermediate Clinical Course.弥漫性血管造影阴性蛛网膜下腔出血与中等临床病程相关。
Neurocrit Care. 2022 Jun;36(3):1002-1010. doi: 10.1007/s12028-021-01413-y. Epub 2021 Dec 21.
8
Spontaneous angiogram-negative subarachnoid hemorrhage: a retrospective single center cohort study.自发性血管造影阴性蛛网膜下腔出血:一项回顾性单中心队列研究。
Acta Neurochir (Wien). 2022 Jan;164(1):129-140. doi: 10.1007/s00701-021-05069-7. Epub 2021 Dec 1.
9
Short- and long-term outcome of patients with aneurysmal subarachnoid hemorrhage.动脉瘤性蛛网膜下腔出血患者的短期和长期预后。
Neurology. 2020 Sep 29;95(13):e1819-e1829. doi: 10.1212/WNL.0000000000010618. Epub 2020 Aug 13.
10
Increasing numbers of nonaneurysmal subarachnoid hemorrhage in the last 15 years: antithrombotic medication as reason and prognostic factor?过去15年非动脉瘤性蛛网膜下腔出血病例数增加:抗血栓药物是原因及预后因素吗?
J Neurosurg. 2016 Jun;124(6):1731-7. doi: 10.3171/2015.5.JNS15161. Epub 2015 Nov 13.